GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans

BMC Genomics

Volumn 17, Issue 1, 2016, Pages

  Chittoor, Geetha ^a,b   Kent, Jack W ^c   Almeida, Marcio ^d   Puppala, Sobha ^c   Farook, Vidya S ^d   Cole, Shelley A ^c   Haack, Karin ^c   Göring, Harald H H ^d   MacCluer, Jean W ^c   Curran, Joanne E ^d   Carless, Melanie A ^c   Johnson, Matthew P ^d   Moses, Eric K ^e   Almasy, Laura ^d   Mahaney, Michael C ^d   Lehman, Donna M ^f   Duggirala, Ravindranath ^d   Comuzzie, Anthony G ^c   Blangero, John ^d   Voruganti, Venkata Saroja ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d University of Texas Rio Grande Valley School of Medicine   (United States)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f University of Texas Health Science Center   (United States)

Author keywords

CNTN4; Family based study; ITPR1; Joint linkage association approach

Indexed keywords

MESSENGER RNA; URIC ACID; CNTN4 PROTEIN, HUMAN; CONTACTIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ITPR1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CHROMOSOME 3P; CNTN4 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DCP1A GENE; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; ITPR1 GNE; LINKAGE ANALYSIS; MALE; MEXICAN AMERICAN; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TGM4 GENE; TRANSCRIPTION REGULATION; URIC ACID BLOOD LEVEL; BLOOD; CHROMOSOME 3; GENETIC LINKAGE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED;

ADULT; CHROMOSOMES, HUMAN, PAIR 3; CONTACTINS; FEMALE; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MEXICAN AMERICANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; URIC ACID;

EID: 84961990475     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-016-2594-5     Document Type: Article

References (58)

1. Álvarez-Lario B, Macarrón-Vicente J. Uric acid and evolution. Rheumatology (Oxford). 2010;49:2010-5.
2. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, Nakagawa T, Johnson RJ. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol. 2006;17:S165-8.
3. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol. 2006;62:633-44.
4. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol. 2005;1:80-6.
5. Nakagawa T, Kang DH, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, Ejaz AA, Segal M, Johnson RJ. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006;69:1722-5.
6. Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Semin Nephrol. 2011;31:410-9.
7. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63:3136-41.
8. Juraschek SP, Miller 3rd ER, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Arthritis Care Res (Hoboken). 2013;65:127-32.
9. Voruganti VS, Nath SD, Cole SA, Thameem F, Jowett JB, Bauer R, MacCluer JW, Blangero J, Comuzzie AG, Abboud HE, Arar NH. Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans. J Clin Endocrinol Metab. 2009;94:632-8.
10. Voruganti VS, Göring HH, Mottl A, Franceschini N, Haack K, Laston S, Almasy L, Fabsitz RR, Lee ET, Best LG. Genetic influence on variation in serum uric acid in American Indians: the strong heart family study. Hum Genet. 2009;126:667-76.
11. Kraja AT, Hunt SC, Pankow JS, Myers RH, Heiss G, Lewis CE, Rao DC, Province MA. Quantitative trait loci for metabolic syndrome in the Hypertension Genetic Epidemiology Network Study. Obes Res. 2005;13:1885-90.
12. Voruganti VS, Kent Jr JW, Debnath S, Cole SA, Haack K, Göring HH, Carless MA, Curran JE, Johnson MP, Almasy L. Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans. Front Genet. 2013;4:279.
13. Voruganti VS, Franceschini N, Haack K, Laston S, MacCluer JW, Umans JG, Comuzzie AG, North KE, Cole SA. Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians. Eur J Hum Genet. 2014;22:938-43.
14. Voruganti VS, Laston S, Haack K, Mehta NR, Cole SA, Butte NF, Comuzzie AG. Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study. Am J Clin Nutr. 2015;101:725-32.
15. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, Lai S, Dei M, Orrù M, Albai G. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3:e194.
16. Döring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, Fischer G, Henke K, Klopp N, Kronenberg F. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40:430-6.
17. McArdle PF, Parsa A, Chang YP, Weir MR, O'Connell JR, Mitchell BD, Shuldiner AR. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order Amish. Arthritis Rheum. 2008;58:2874-81.
18. Karns R, Zhang G, Sun G, Rao Indugula S, Cheng H, Havas-Augustin D, Novokmet N, Rudan D, Durakovic Z, Missoni S. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet. 2012;76:121-7.
19. Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953-61.
20. Charles BA, Shriner D, Doumatey A, Chen G, Zhou J, Huang H, Herbert A, Gerry NP, Christman MF, Adeyemo A. A genome-wide association study of serum uric acid in African Americans. BMC Med Genomics. 2011;4:17.
21. Zhang L, Spencer KL, Voruganti VS, Jorgensen NW, Fornage M, Best LG, Brown-Gentry KD, Cole SA, Crawford DC, Deelman E. Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study. Am J Epidemiol. 2013;177:923-32.
22. Cargile CB, Goh DL, Goodman BK, Chen XN, Korenberg JR, Semenza GL, Thomas GH. Molecular cytogenetic characterization of a subtle interstitial del(3)(p253p262) in a patient with deletion 3p syndrome. Am J Med Genet. 2002;109:133-8.
23. Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, Lifton RP, State MW. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet. 2004;74:1286-93.
24. Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB. Urate predicts rate of clinical decline in Parkinson disease. Arch Neurol. 2009;66:1460-8.
25. Euser SM, Hofman A, Westendorp RG, Breteler MM. Serum uric acid and cognitive function and dementia. Brain. 2009;132:377-82.
26. Moccia M, Lanzillo R, Palladino C, Carotenuto A, Massarelli M, Vacca G, Vacchiano V, Nardone A, Triassi M, Morra VB. Uric acid: a potential biomarker of multiple sclerosis and of its disability. Clin Chem Lab Med. 2015;53:753-9.
27. Mousavi M, Jonsson P, Antti H, Adilfsson R, Nordin A, Bergdahl J, Eriksson K, Moritz T, Nisson LG, Nyberg L. Serum metabolomics biomarkers of dementia. Dement Geriatr Cogn Disord Extra. 2014;4:252-62.
28. Zhu A, Zou T, Xiong G, Zhang J. Association of uric acid with traditional inflammatory factors in stroke. Int J Neurosci. 2016;126:335-41.
29. Göring HHH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, Cole SA, Jowett JBM, Abraham LJ, Rainwater DL, Comuzzie AG. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet. 2007;39:1208-16.
30. Roohi J, Montagna C, Tegay DH, Palmer LE, DeVincent C, Pomeroy JC, Christian SL, Nowak N, Hatchwell E. Disruption of contactin 4 in three subjects with autism spectrum disorder. J Med Genet. 2009;46:176-82.
31. Cottrell CE, Bir N, Varga E, Alvarez CE, Bouvain S, Zernzach R, Thrush DL, Evans J, Trimarchi M, Butter EM. Contactin 4 as an autism susceptibility locus. Autism Res. 2011;4:189-99.
32. Poot M. A candidate gene association study further corroborates involvement of contactin genes in autism. Mol Syndromol. 2014;5:229-35.
33. Sui WG, He HY, Yan Q, Chen JJ, Zhang RH, Dai Y. ChIP-seq analysis of histone H3K9 trimethylation in peripheral blood mononuclear cells of membranous nephropathy patients. Braz J Med Biol Res. 2014;47:42-9.
34. Constantinescu R, Zetterberg H. Urate as a marker of development and progression in Parkinson's disease. Drugs Today (Barc). 2011;47:369-80.
35. Spitsin S, Koprowski H. Role of uric acid in multiple sclerosis. Curr Top Microbiol Immunol. 2008;318:325-42.
36. Spitsin S, Koprowski H. Role of uric acid in Alzheimer's disease. J Alzheimers Dis. 2010;19:1337-8.
37. Du N, Xu D, Hou X, Song X, Liu C, Chen Y, Wang Y, Li X. Inverse association between serum uric acid levels and Alzheimer's disease risk. Mol Neurobiol. 2015; Jun 18 [Epub ahead of print].
38. Vannorsdall TD, Jinnah HA, Gordon B, Kraut M, Schretlen DJ. Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke. 2008;39:3418-20.
39. Cicero AF, Desideri G, Grossi G, Urso R, Rosticci M, D'Addato S, Borghi C, Brisighella Heart Study group. Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study. Intern Emerg Med. 2015;10:25-31.
40. Berridge M. Inositol trisphosphate and calcium signaling. Nature. 1993;361:315-25.
41. Schwartzentruber J, Zou R, Schofield PW, Douglas S, Bulman DE, et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis. 2012;7:67.
42. Jones CI, Bray S, Garner SF, Stephens J, de Bono B, Angenent WG, Bentley D, Coffey A, Deloukas P, Earthrowl M. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood. 2009;114:1405-16.
43. Bai RY, Koester C, Ouyang T, Hahn SA, Hammerschmidt M, Peschel C, et al. SMIF, a Smad4-interacting protein that functions as a co-activator in TGF-beta signaling. Nature Cell Biol. 2002;4:181-90.
44. Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. J Child Neurol. 2008;23:307-14.
45. Zecavati N, Spence SJ. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep. 2009;9:129-36.
46. Masino SA, Kawamura Jr M, Cote JL, Williams RB, Ruskin DN. Adenosine and autism: a spectrum of opportunities. Neuropharmacology. 2013;68:116-21.
47. Veerama KR, O'Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, Waxman SG, Talwar D, Girirajan S, Eichler EE, Restifo LL. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012;90:502-10.
48. MacCluer JW, Stern MP, Almasy L, Atwood LA, Blangero J, Comuzzie AG, Dyke B, Haffner SM, Henkel RD, Hixson JE. Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev. 1999;57:S59-65.
49. Mitchell BD, Almasy LA, Rainwater DL, Schneider JL, Blangero J, Stern MP, MacCluer JW. Diabetes and hypertension in Mexican American families: relation to cardiovascular risk. Am J Epidemiol. 1999;149:1047-56.
50. Duggirala R, Mitchell BD, Blangero J, Stern MP. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol. 1999;16:191-204.
51. Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, Granato R, Dyer TD, Almasy L, Jenkinson CP. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet. 2006;78:377-92.
52. Domagk GF, Schlicke HH. A colorimetric method using uricase and peroxidase for the determination of uric acid. Anal Biochem. 1968;22:219-24.
53. Arar NH, Voruganti VS, Nath SD, Thameem F, Bauer R, Cole SA, Blangero J, MacCluer JW, Comuzzie AG, Abboud HE. A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol Dial Transplant. 2008;23:3184-91.
54. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2009;30:97-101.
55. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet. 1996;58:1323-37.
56. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-211.
57. Boerwinkle E, Chakroborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet. 1986;50:181-94.
58. Moskvina V, Schmidt KM. On multiple testing in genome-wide association studies. Genet Epidemiol. 2008;32:567-73.